Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects. (Record no. 17228346)

MARC details
000 -LEADER
fixed length control field 01317 a2200349 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515080419.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200709s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-7666
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1517/14656566.8.12.1985
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pfützner, Andreas
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070906
245 00 - TITLE STATEMENT
Title Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Expert opinion on pharmacotherapy
Date of publication, distribution, etc. Aug 2007
300 ## - PHYSICAL DESCRIPTION
Extent 1985-98 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Atherosclerosis
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cardiovascular Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 2
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fatty Liver
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypoglycemic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element PPAR gamma
General subdivision agonists
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pioglitazone
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thiazolidinediones
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weber, Matthias M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Forst, Thomas
773 0# - HOST ITEM ENTRY
Title Expert opinion on pharmacotherapy
Related parts vol. 8
-- no. 12
-- p. 1985-98
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1517/14656566.8.12.1985">https://doi.org/10.1517/14656566.8.12.1985</a>
Public note Available from publisher's website

No items available.